Connect with us
Spain’s health ministry has approved funding for Tofersen (Qalsody), the first EU-approved drug targeting a genetic cause of ALS—SOD1 mutations. This personalized therapy silences the gene...
Barcelona hosts the KRAS Think Tank Meeting, uniting global experts to share cutting-edge research on the KRAS oncogene, mutated in many cancers. Led by Dr. Rafael...
In 2024, Spain’s pharmaceutical industry surpassed €1.5 billion in R&D investment, emphasizing clinical research and collaborations beyond universities. Nearly 45% of projects involve hospitals and research...
Bladder cancer treatment has advanced significantly, doubling survival in some stages. In Spain, experts urge improved access and multidisciplinary care. The II Bladder Cancer Conference stressed...
The European Commission launched a public consultation on the EU Biotechnology Law, aiming to boost competitiveness and safety in the biotech sector. Open until June 11,...
Researchers from INCLIVA developed a blood-based test, TAV16, to detect micrometastases in early-stage colon cancer with unprecedented sensitivity. Using ctDNA analysis, it predicts relapse risk more...
Vytrus Biotech reported 76% sales growth in Q1 2025, with standout gains in Asia-Pacific (271%) and strong global performance. EBITDA doubled to €1.02 million. Its Exosomic...
Gilead Spain and Portugal, with AEEH, launched the 8th Gilead-AEEH Grants to support Hepatitis D diagnosis and Hepatitis C microelimination, with €390,000 funding. Eligible nonprofits may...
Barcelona-based DeepUll raised €50 million in Series C funding to validate UllCORE, a rapid sepsis diagnostic tool. The test identifies 95% of sepsis pathogens within an...
Leo Pharma’s Spanish unit earned €97M in 2024, up 4% from 2023, led by dermatology (€61.2M, 67% of revenue). Biodermatology grew over 20%, driven by Adtralza....